Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

EMAS position statement:Testosterone replacement therapy in the aging male‏

Title: EMAS position statement:Testosterone replacement therapy in the aging male‏
Authors: Dimopoulou,Christina; Ceausu,Iuliana; Depypere,Herman; Lambrinoudaki,Irene; Mueck,Alfred; Pérez-López,Faustino R; Rees,Margaret; van der Schouw, Yvonne T; Senturk,Levent M; Simonsini,Tommaso; Stevenson,John C; Stute,Petra; Goulis,Dimitrios G; JC onderzoeksprogramma Cardiovascular Health; Circulatory Health; Cardiovasculaire Epidemiologie
Publication Year: 2016
Subject Terms: Aging male; Late-onset hypogonadism; Testosterone replacement; Journal Article; Review
Description: INTRODUCTION: Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, characterized by the presence of symptoms (most usually of a sexual nature, such as decreased libido, decreased spontaneous erections and erectile dysfunction) and signs, in combination with low serum testosterone concentrations. Whether testosterone replacement therapy (TRT) should be offered to those individuals is still under extensive debate. AIMS: The aim of this position statement is to provide and critically appraise evidence on TRT in the aging male, focusing on pathophysiology and characteristics of LOH, indications for TRT, available therapeutic agents, monitoring and treatment-associated risks. MATERIALS AND METHODS: Literature review and consensus of expert opinion. RESULTS AND CONCLUSIONS: Diagnosis and treatment of LOH is justified, if a combination of symptoms of testosterone deficiency and low testosterone is present. Patients receiving TRT could profit with regard to obesity, metabolic syndrome, type 2 diabetes mellitus, sexual function and osteoporosis and should undergo scheduled testing for adverse events regularly. Potential adverse effects of TRT on cardiovascular disease, prostate cancer and sleep apnea are as yet unclear and remain to be investigated in large-scale prospective studies. Management of aging men with LOH should include individual evaluation of co-morbidities and careful risk versus benefit assessment.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
ISSN: 0378-5122
Relation: https://dspace.library.uu.nl/handle/1874/333064
Availability: https://dspace.library.uu.nl/handle/1874/333064
Rights: info:eu-repo/semantics/ClosedAccess
Accession Number: edsbas.206EEA7B
Database: BASE